Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, have garnered a ...

Adare Pharma Solutions, a tech driven CDMO specializing in oral dosage forms, has announced expansions of its high potency ...

UK-based pharma manufacturer Ennogen has received a £30 million credit facility from Santander UK to support its ...

Renée Aguiar-Lucander, CEO of Calliditas, is driving the advancement and launch of TARPEYO – the company’s medication targeting rare disease IgA nephropathy. We spoke with Renée about her journey from ...

Almost half of all strategic alliances focused on RNA therapies over the last five years in the Asia-Pacific (APAC) region ...

Pfizer's groundbreaking $3.5 million gene therapy for Hemophilia B just got FDA approval. Here’s what it means for patients ...

Bristol Myers Squibb partners with Repertoire Immune Medicines to develop innovative vaccines aimed at treating autoimmune ...

With equipment that promises to produce 10 times more therapies, the deal with Cellares is hoped to make BSM's CAR-T ...

The UK/Irish company SynOx Therapeutics plans to run a phase 3 trial of a potentially best-in-class antibody therapy for the ...

In a recent interview, Hayley Crowe, head of Ecolab's global life sciences business, shed light on Purolite's latest ...

UK-based biotech Glen Clova Scientific has raised £4 million in seed financing to develop a pipeline of a new generation of ...

UK-based biotech Glen Clova Scientific has raised £4 million in seed financing to develop a pipeline of a new generation of active biologic drugs. The round was led by Norcliffe Capital together with ...